Big Pharma turns to China for future deals - The American Bazaar

Summary

The article discusses the increasing collaboration between U.S. pharmaceutical companies and Chinese firms in biotechnology, highlighting significant investments and partnerships as seen with Merck & Co., Moderna, and Bain Capital. This reflects a shift towards leveraging China's biotech market despite geopolitical tensions, emphasizing global interdependence in medical research and drug development. The key concept of 'Biotechnology' connects with the pharmaceutical industry's evolving landscape in both the U.S. and China. Tags such as 'Medical research' and companies like 'Jiangsu Hengrui' and 'GlaxoSmithKline' further illustrate this trend.